OPTIKIRA LLC;THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
发明人:
申请号：
IL27284520
公开号：
IL272845D0
申请日:
2020.02.23
申请国别(地区):
IL
年份:
2020
代理人:
摘要：
The present invention provides novel compounds, compositions and methods for treating or preventing an IRE1α-related disease or disorder. In certain embodiments, the disease or disorder is selected from the group consisting of a neurodegenerative disease, a demyelinating disease, cancer, an eye disease, a fibrotic disease, and diabetes.
